EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling.
Liu ZK, Li C, Zhang RY, Wei D, Shang YK, Yong YL, Kong LM, Zheng NS, Liu K, Lu M, Liu M, Hu CX, Yang XZ, Chen ZN, Bian H.
Liu ZK, et al. Among authors: shang yk.
Mol Cancer. 2021 May 27;20(1):79. doi: 10.1186/s12943-021-01377-9.
Mol Cancer. 2021.
PMID: 34044846
Free PMC article.